Terms: = Liver cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Clinical Outcome
19 results:
1. Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study.
Iwaki M; Fujii H; Hayashi H; Toyoda H; Oeda S; Hyogo H; Kawanaka M; Morishita A; Munekage K; Kawata K; Tsutsumi T; Sawada K; Maeshiro T; Tobita H; Yoshida Y; Naito M; Araki A; Arakaki S; Kawaguchi T; Noritake H; Ono M; Masaki T; Yasuda S; Tomita E; Yoneda M; Tokushige A; Kamada Y; Takahashi H; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T
Clin Mol Hepatol; 2024 Apr; 30(2):225-234. PubMed ID: 38263684
[TBL] [Abstract] [Full Text] [Related]
2. metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
Sacco M; Ribaldone DG; Saracco GM
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140692
[TBL] [Abstract] [Full Text] [Related]
3. clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
Pageaux GP; Nzinga CL; Ganne N; Samuel D; Dorival C; Zoulim F; Cagnot C; Decaens T; Thabut D; Asselah T; Mathurin P; Habersetzer F; Bronowicki JP; Guyader D; Rosa I; Leroy V; Chazouilleres O; de Ledinghen V; Bourliere M; Causse X; Cales P; Metivier S; Loustaud-Ratti V; Riachi G; Alric L; Gelu-Simeon M; Minello A; Gournay J; Geist C; Tran A; Abergel A; Portal I; d'Alteroche L; Raffi F; Fontaine H; Carrat F; Pol S;
BMC Infect Dis; 2022 Jan; 22(1):94. PubMed ID: 35086481
[TBL] [Abstract] [Full Text] [Related]
4. Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse clinical outcome.
Li D; Yu T; Hu J; Wu J; Feng S; Xu Q; Zhu H; Zhang X; Zhang Y; Zhou B; Gu L; Zeng Z
Oxid Med Cell Longev; 2021; 2021():5175581. PubMed ID: 35003516
[TBL] [Abstract] [Full Text] [Related]
5. Low Frequency of Acute Pancreatitis in Hospitalized COVID-19 Patients.
Troncone E; Salvatori S; Sena G; De Cristofaro E; Alfieri N; Marafini I; Paganelli C; Argirò R; Giannarelli D; Monteleone G; Del Vecchio Blanco G
Pancreas; 2021 Mar; 50(3):393-398. PubMed ID: 33835971
[TBL] [Abstract] [Full Text] [Related]
6. YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-met Signaling in liver Tumorigenesis.
Thomann S; Weiler SME; Marquard S; Rose F; Ball CR; Tóth M; Wei T; Sticht C; Fritzsche S; Roessler S; De La Torre C; Ryschich E; Ermakova O; Mogler C; Kazdal D; Gretz N; Glimm H; Rempel E; Schirmacher P; Breuhahn K
Cancer Res; 2020 Dec; 80(24):5502-5514. PubMed ID: 33087321
[TBL] [Abstract] [Full Text] [Related]
7. Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria.
Shi F; Lian S; Mai Q; Mo Z; Zhuang W; Cui W; Shen L; Chen M; Wu P; Chen X
Eur Radiol; 2020 May; 30(5):2454-2462. PubMed ID: 32002636
[TBL] [Abstract] [Full Text] [Related]
8. clinical outcome of open surgery versus laparoscopic surgery for cirrhotic hepatocellular carcinoma patients: a meta-analysis.
Xing L; Guo HB; Kan JL; Liu SG; Lv HT; Liu JH; Bian W
Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):239-245. PubMed ID: 31567715
[TBL] [Abstract] [Full Text] [Related]
9. Systematic review with meta-analysis: high mortality in patients with non-severe alcoholic hepatitis.
Bennett K; Enki DG; Thursz M; Cramp ME; Dhanda AD
Aliment Pharmacol Ther; 2019 Aug; 50(3):249-257. PubMed ID: 31231848
[TBL] [Abstract] [Full Text] [Related]
10. Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma.
Dai B; Zhang X; Shang R; Wang J; Yang X; Zhang H; Liu Q; Wang D; Wang L; Dou K
Cell Commun Signal; 2018 Dec; 16(1):99. PubMed ID: 30545369
[TBL] [Abstract] [Full Text] [Related]
11. Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review.
Feingold PL; Klemen ND; Kwong MLM; Hashimoto B; Rudloff U
Int J Hyperthermia; 2018 Aug; 34(5):501-511. PubMed ID: 29214884
[TBL] [Abstract] [Full Text] [Related]
12. Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis.
Cheng WL; Qi YQ; Wang B; Tian L; Huang W; Chen Y
Ann R Coll Surg Engl; 2017 Mar; 99(3):237-241. PubMed ID: 27869486
[TBL] [Abstract] [Full Text] [Related]
13. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors.
Ma S; Ding M; Li J; Wang T; Qi X; Shi Y; Ming Y; Chi J; Wang Z; Tang X; Cui D; Zhang Y; Zhai B
J Cancer Res Clin Oncol; 2017 Jan; 143(1):131-142. PubMed ID: 27650934
[TBL] [Abstract] [Full Text] [Related]
14. cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-met/FRA1/HEY1 Signaling.
Lau EY; Lo J; Cheng BY; Ma MK; Lee JM; Ng JK; Chai S; Lin CH; Tsang SY; Ma S; Ng IO; Lee TK
Cell Rep; 2016 May; 15(6):1175-89. PubMed ID: 27134167
[TBL] [Abstract] [Full Text] [Related]
15. Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.
Petrillo M; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Vizzielli G; Pedone Anchora L; Nero C; Margariti PA; Scambia G
Gynecol Oncol; 2013 Oct; 131(1):36-41. PubMed ID: 23791829
[TBL] [Abstract] [Full Text] [Related]
16. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
[TBL] [Abstract] [Full Text] [Related]
17. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
Vora SR; Zheng H; Stadler ZK; Fuchs CS; Zhu AX
Oncologist; 2009 Jul; 14(7):717-25. PubMed ID: 19581525
[TBL] [Abstract] [Full Text] [Related]
18. meta-analysis of clinical outcome after first and second liver resection for colorectal metastases.
Antoniou A; Lovegrove RE; Tilney HS; Heriot AG; John TG; Rees M; Tekkis PP; Welsh FK
Surgery; 2007 Jan; 141(1):9-18. PubMed ID: 17188163
[TBL] [Abstract] [Full Text] [Related]
19. Biomarker discovery in urogenital cancer.
Said J
Biomarkers; 2005 Nov; 10 Suppl 1():S83-6. PubMed ID: 16298916
[TBL] [Abstract] [Full Text] [Related]
